Skip to content

Alfentanil under closed-loop target-controlled propofol is used in very elderly patients with ERCP EC50

Alfentanil under closed-loop target-controlled propofol is used in very elderly patients with ERCP EC50

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400082734
Enrollment
Unknown
Registered
2024-04-07
Start date
2024-04-07
Completion date
Unknown
Last updated
2024-04-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreaticobiliary duct disease

Interventions

Alfentanil group:Alfentanil 0.25 µg / kg / min was given after loss of consciousness ( OAA / S = 2 ). The continuous infusion concentration of alfentanil was determined by half-effect sequential meth

Sponsors

Weifang People 's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1, super-aged ( > 85 years old ) patients undergoing ERCP. 2, ASA grade 2 or 3.

Exclusion criteria

Exclusion criteria: 1.Patients who do not meet the inclusion criteria and are mistakenly included ; 2.Patients with blood pressure fluctuations more than 20 % after admission, or re-intubation / intubation time is too long, or no follow-up records ; 3.Patients take unspecified drug combinations, especially drugs that have a greater impact on clinical outcomes, efficacy and safety. 4.Patients with severe cardiovascular and cerebrovascular diseases.

Design outcomes

Primary

MeasureTime frame
Alfentanil EC50;

Secondary

MeasureTime frame
Perioperative cognitive function;

Countries

China

Contacts

Public ContactYanhua Luo

Weifang People 's Hospital

55358645@qq.com+86 156 2421 0595

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026